Bo-Christer Björk | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Posts Tagged ‘Bo-Christer Björk’

SAME SCIENTIFIC IMPACT: Scientific Publishing – Open Journals vs. Subscription-based

Posted in Alzheimer's Disease, Bio Instrumentation in Experimental Life Sciences Research, Biological Networks, Gene Regulation and Evolution, Biomarkers & Medical Diagnostics, BioSimilars, Bone Disease and Musculoskeletal Disease, CANCER BIOLOGY & Innovations in Cancer Therapy, Cardiovascular Pharmacogenomics, Cell Biology, Signaling & Cell Circuits, Chemical Biology and its relations to Metabolic Disease, Chemical Genetics, Computational Biology/Systems and Bioinformatics, Disease Biology, Small Molecules in Development of Therapeutic Drugs, Ecosystems & Industrial Concentration in the Medical Device Sector, FDA Regulatory Affairs, Frontiers in Cardiology and Cardiovascular Disorders, Genome Biology, Health Economics and Outcomes Research, HealthCare IT, Infectious Disease & New Antibiotic Targets, Innovations in Neurophysiology & Neuropsychology, International Global Work in Pharmaceutical, Liver & Digestive Diseases Research, Medical and Population Genetics, Medical Devices R&D Investment, Metabolomics, Nutrigenomics, Nutrition, Origins of Cardiovascular Disease, Pain: Etiology, Genetics & Innovations in Treatment, Personalized and Precision Medicine & Genomic Research, Pharmaceutical Analytics, Pharmaceutical Industry Competitive Intelligence, Pharmaceutical R&D Investment, Pharmacotherapy of Cardiovascular Disease, Population Health Management, Genetics & Pharmaceutical, Population Health Management, Nutrition and Phytochemistry, Proteomics, Regulated Clinical Trials: Design, Methods, Components and IRB related issues, Reproductive Biology & Bio Instrumentation, Statistical Methods for Research Evaluation, Systemic Inflammatory Response Related Disorders, tagged BMC Medicine, Bo-Christer Björk, David Solomon, Hanken School of Economics, http://pharmaceuticalintelligence.com, http://www.facebook.com/LeadersInPharmaceuticalBusinessIntelligence, http://www.linkedin.com/groups?gid=4346921&trk=hb_side_g, http://www.linkedin.com/in/avivalevari, https://sites.google.com/site/avivasopusmagnum/aviva-s-home-page, https://twitter.com/#!/pharma_BI, Michigan State University, Open access, Open access journal, Research Methodology, Scientific Web site on July 23, 2012| 2 Comments »

Reporters: Aviva Lev-Ari, PhD, RN & Pnina G. Abir-Am, PhD

Drastic change in academic education by design: FREE ACCESS to knowledge — Program edX – the Harvard+MIT collaboration on Online education!!

FREE ACCESS to Scientific Journals will be the next step. Research to support that by a study carried by Bjork, B. C., and D. Solomon. 2012. Open access versus subscription journals: a comparison of scientific impact. BMC Medicine. 10(1):73+.

“Following step will be to demonstrated that Scientific Websites like http://pharmaceuticalintelligence.com have SAME Scientific impact as Open Journals!!

“We are well positioned to demonstrate that” said Aviva Lev-Ari, PhD, RN, Director & Founder of Leaders in Pharmaceutical Business Intelligence and the 2/2012 launcher of the initiative called http://pharmaceuticalintelligence.com To trace her contributions to Research Methodology, 1976-2005, go to https://sites.google.com/site/avivasopusmagnum/aviva-s-home-page

The merit of Scientific Website is manifold:

Time from Lab/Desk to Publication on the Internet and Search engines is reduced to seconds
comments by other scientists are equally valuable to peer review
collaboration with other scientist around the globe is fostered on WWW
the platform is of collaborative authoring, we have 60 categories of research in one site
interdisciplinary work can be published in one site the over arching domain in our case is Life Sciences, Pharmaceutical and Healthcare

In May 2012 MIT and Harvard are collaborating on distribution of course material of all classes on the Internet – a Program called EdX

http://www.edxonline.org/

In the Press Release“EdX represents a unique opportunity to improve education on our own campuses through online learning, while simultaneously creating a bold new educational path for millions of learners worldwide,” MIT President Susan Hockfield said.

Harvard President Drew Faust said, “edX gives Harvard and MIT an unprecedented opportunity to dramatically extend our collective reach by conducting groundbreaking research into effective education and by extending online access to quality higher education.”

“Harvard and MIT will use these new technologies and the research they will make possible to lead the direction of online learning in a way that benefits our students, our peers, and people across the nation and the globe,” Faust continued.

Princeton, Stanford, Michigan and the University of Pennsylvania announced that they would offer free Web-based courses through a for-profit company called Coursera that was founded by two Stanford computer science professors. One of those professors, Andrew Ng, taught a free online course in machine learning this past fall with an enrollment of more than 100,000 students.

There’s also Udacity, co-founded by a former Stanford professor, andKhan Academy, which boasts 3,100 free educational videos across a variety of subjects.

MIT and Harvard said that they hope to eventually partner with other universities to expand the offerings on the edX platform.

http://www.edxonline.org/release.html

http://money.cnn.com/2012/05/02/technology/harvard-mit-online/index.htm

Results of the BMC Medicine study are reported, below and they are: Open Access, But Same Impact

BioTechniques

http://www.biotechniques.com/news/Open-Access-But-Same-Impact/biotechniques-333012.html#.UA2SsRxueMU

Open Access, But Same Impact

07/19/2012

Jesse Jenkins

By comparing two-year impact factors for journals, researchers found that open access and subscription-based journals have about the same scientific impact.

Open access (OA) journals are approaching the same scientific impact and quality as traditional subscription journals, according to a new study. In a study published in BMC Medicine on July 17 (1), researchers surveyed the impact factors, the average number of citations per paper published in a journal during the two preceding years, of OA and traditional subscription journals.

By comparing two-year impact factors for journals from the four countries that publish the most scientific literature, researchers have found that OA journals have about the same scientific impact as their subscription-based counterparts. Source: BMC Medicine.

At first, the study’s authors—Bo-Christer Björk from the Hanken School of Economics in Helsinki, Finland, and David Solomon from the College of Human Medicine at Michigan State University—found that there was a 30% higher average citation rate for subscription journals. But after controlling for journal discipline, location of publisher, and age of publication, their results showed that OA and subscription journals had nearly identical scientific impact.

“The newer open access published within the last 10 years, particularly those journals funded by article processing fees, had basically the same impact as subscription journals within the same category,” said Solomon. “I think that that is the key finding.”

The initial higher citation rate for subscription journals was the result of a higher percentage of older OA journals from countries that are not major publishing countries. “A lot of them are from South America or other developing countries, and they tend to have lower impact factors,” said Solomon. “When you compare apples to apples and start looking within subgroups, particularly journals launched after 2000 in biomedicine for example, the differences fall away.”

However, the authors identified a sector of low quality, OA publishers that are looking to capitalize on the article processing charge model rather than contribute to the advancement of science. Solomon said that this could partly be to blame for negative perceptions about the integrity of OA publishing as a whole and its impact on the peer review system. But most researchers are aware of these low-quality publishers and prefer to publish in more reputable OA journals.

In the end, Bjork and Solomon are hopeful that the study’s findings may help dispel some of the misconceptions in the debate over OA publishing. “Open access journals still have the reputation of being second class in the minds of some people. So, we think that this is important because this is objective data verifying that at least the open access journals published in the last 10 years by professional publishers are on par with subscription journals.”

References